$STIM - 👆Up 6.8% Pre-Market/ Current Price $2.06 Reports Record Q2 '23 Financial & Operating Results 👉Q2 '23 revenue of $17.6m, an increase of 8% over the Q2 '22 👉U.S. treatment session revenue increased 9% over the Q2 of '22 👉Shipped 54 NeuroStar systems
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.